Ann Coloproctol.
2015 Jun;31(3):81-81. 10.3393/ac.2015.31.3.81.
ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
- Affiliations
-
- 1Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea. ssurge@sch.ac.kr
- KMID: 2169725
- DOI: http://doi.org/10.3393/ac.2015.31.3.81
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Adjuvant Chemotherapy in Colon Cancer
- Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
- Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
- Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
- Chemotherapy for Colorecal Cancer
